1. CSIG-04. A REQUIREMENT FOR RIOK2 CATALYTIC ACTIVITY IN RTK-PI3K DEPENDENT GLIOBLASTOMA. (5th November 2018) Authors: Boyd, Nathaniel; Chen, Alexander; Marquez, Jhomar; Read, Renee Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CSIG-11. UNDERSTANDING THE MECHANISM OF RIOK2 FUNCTION IN GLIOBLASTOMA. (5th November 2018) Authors: Chen, Alexander; Read, Renee Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DDDR-14. YAP/TAZ TRANSCRIPTIONAL CO-ACTIVATORS DRIVE NEURO-GLIAL STEM/PROGENITOR CELL IDENTITY IN HIGH GRADE GLIOMAS. (14th November 2022) Authors: Read, Renee; Oh, Se-Yeong; Vigneswaran, Krishanthan; Boyd, Nathaniel; Young, Elizabeth; Read, William; Olson, Jeffrey Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EXTH-27. YAP/TAZ TRANSCRIPTIONAL CO-ACTIVATORS CREATE THERAPEUTIC VULNERABILITY TO VERTEPORFIN IN EGFR MUTANT GLIOBLASTOMA. (9th November 2020) Authors: Read, Renee; Vigneswaran, Krishanthan; Boyd, Nathaniel; Oh, Se-Yeong; Lallani, Shoeb; Boucher, Andrew; Neill, Stewart; Olson, Jeffrey Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗